Tag: 上海品茶网VYW

Watch: CEO Daniel O’Day says Gilead is in a ‘sweet spot.’ What’s next?

first_img Log In | Learn More Watch: CEO Daniel O’Day says Gilead is in a ‘sweet spot.’ What’s next? What’s Gilead going to buy?That’s the single, persistent question Daniel O’Day has faced in his first months on the job as CEO of Gilead Sciences.  By STAT staff Jan. 31, 2020 Reprints Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Tags biotechnologyfinanceSTAT SummitSTAT+ About the Author Reprints STAT staffcenter_img What’s included? STAT Summit What is it? Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Gilead CEO Daniel O’Day Emilie Pickering for STAT [email protected] GET STARTEDlast_img read more